Gamma Oryzanol Market Analysis By Application (Sports Supplement, Cosmetics, Pharmaceuticals, Animal Feed) And Segment Forecasts To 2022
The global gamma oryzanol market is expected to reach USD 2.06 billion by 2022, according to a new report by Grand View Research, Inc. Increasing consumer awareness towards a healthy lifestyle is expected to drive product demand over the next seven years.
CHAPTER 1 METHODOLOGY & SCOPE
1.1 Research Methodology
1.2 Research Scope & Assumptions
1.3 List of Data Sources
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Gamma Oryzanol - Industry Summary And Key Buying Criteria
CHAPTER 3 GAMMA ORYZANOL INDUSTRY OUTLOOK
3.1 Market Segmentation
3.2 Market size and growth prospects, 2012 - 2022
3.3 Gamma oryzanol value chain analysis
3.3.1 Vendor landscape
3.4 Raw material trend
3.5 Regulatory framework
3.6 Gamma oryzanol market dynamics
3.6.1 Market driver analysis
3.6.1.1 Growing sports supplements industry
3.6.1.2 Growing natural ingredients demand in cosmetics
3.6.2 Market restraint analysis
3.6.2.1 Low consumer awareness
3.7 Key opportunities prioritized
3.8 Gamma oryzanol - Porter’s analysis
3.9 Gamma oryzanol - PESTEL analysis
CHAPTER 4 GAMMA ORYZANOL APPLICATION OUTLOOK
4.1 Global gamma oryzanol market share by application, 2014 & 2022
4.2 Sports Supplements
4.2.1 Market estimates and forecast, 2012 - 2022
4.2.2 Market estimates and forecast by region, 2012 - 2022
4.3 Cosmetics
4.3.1 Market estimates and forecast, 2012 - 2022
4.3.2 Market estimates and forecast by region, 2012 - 2022
4.4 Pharmaceuticals
4.4.1 Market estimates and forecast, 2012 - 2022
4.4.2 Market estimates and forecast by region, 2012 - 2022
4.5 Animal feed
4.5.1 Market estimates and forecast, 2012 - 2022
4.5.2 Market estimates and forecast by region, 2012 - 2022
CHAPTER 6 GAMMA ORYZANOL REGIONAL OUTLOOK
6.1 Global gamma oryzanol market volume share by region, 2014&2022
6.2 North America
6.2.1 Market estimates and forecast, 2012 - 2022
6.2.2 Market estimates and forecast by application, 2012 - 2022
6.2.3 U.S.
6.2.4.1 Market estimates and forecast, 2012 - 2022
6.2.4.2 Market estimates and forecast by application, 2012 - 2022
6.3 Europe
6.3.1 Market estimates and forecast, 2012 - 2022
6.3.2 Market estimates and forecast by application, 2012 - 2022
6.3.3 France
6.3.4.1 Market estimates and forecast, 2012 - 2022
6.3.4.2 Market estimates and forecast by application, 2012 - 2022
6.3.4 Germany
6.3.5.1 Market estimates and forecast, 2012 - 2022
6.3.5.2 Market estimates and forecast by application, 2012 - 2022
6.3.5 UK
6.3.6.1 Market estimates and forecast, 2012 - 2022
6.3.6.2 Market estimates and forecast by application, 2012 - 2022
6.4 Asia Pacific
6.4.1 Market estimates and forecast, 2012 - 2022
6.4.2 Market estimates and forecast by application, 2012 - 2022
6.4.3 China
6.4.4.1 Market estimates and forecast, 2012 - 2022
6.4.4.2 Market estimates and forecast by application, 2012 - 2022
6.4.4 India
6.4.5.1 Market estimates and forecast, 2012 - 2022
6.4.5.2 Market estimates and forecast by application, 2012 - 2022
6.5 Central & South America (CSA)
6.5.1 Market estimates and forecast, 2012 - 2022
6.5.2 Market estimates and forecast by application, 2012 - 2022
6.6 Middle East & Africa (MEA)
6.6.1 Market estimates and forecast, 2012 - 2022
6.6.2 Market estimates and forecast by application, 2012 - 2022
CHAPTER 7 COMPETITIVE LANDSCAPE
7.1 Oryza Oil & Fat Chemical Co., Ltd
7.1.1 Company Overview
7.1.2 Financial Performance
7.1.3 Product Benchmarking
7.1.4 Strategic Initiatives
7.2 Jining Ankang Pharmaceutical
7.2.1 Company Overview
7.2.2 Financial Performance
7.2.3 Product Benchmarking
7.2.4 Strategic Initiatives
7.3 KangCare
7.3.1 Company Overview
7.3.2 Financial Performance
7.3.3 Product Benchmarking
7.3.4 Strategic Initiatives
7.4 Lamotte Oils
7.4.1 Company Overview
7.4.2 Financial Performance
7.4.3 Product Benchmarking
7.4.4 Strategic Initiatives
7.5 Tsuno Rice
7.5.1 Company Overview
7.5.2 Financial Performance
7.5.3 Product Benchmarking
7.5.4 Strategic Initiatives
7.6 Xi'an Realin Biotechnology
7.6.1 Company Overview
7.6.2 Financial Performance
7.6.3 Product Benchmarking
7.6.4 Strategic Initiatives
7.7 Honson Pharmatech Group
7.7.1 Company Overview
7.7.2 Financial Performance
7.7.3 Product Benchmarking
7.7.4 Strategic Initiatives
7.8 Shanghai Freemen, LLC
7.8.1 Company Overview
7.8.2 Financial Performance
7.8.3 Product Benchmarking
7.8.4 Strategic Initiatives
7.9 Chromadex International
7.9.1 Company Overview
7.9.2 Financial Performance
7.9.3 Product Benchmarking
7.9.4 Strategic Initiatives
7.10 Sunrise Nutrachem Group Co., Ltd.
7.10.1 Company Overview
7.10.2 Financial Performance
7.10.3 Product Benchmarking
7.10.4 Strategic Initiatives
1.1 Research Methodology
1.2 Research Scope & Assumptions
1.3 List of Data Sources
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Gamma Oryzanol - Industry Summary And Key Buying Criteria
CHAPTER 3 GAMMA ORYZANOL INDUSTRY OUTLOOK
3.1 Market Segmentation
3.2 Market size and growth prospects, 2012 - 2022
3.3 Gamma oryzanol value chain analysis
3.3.1 Vendor landscape
3.4 Raw material trend
3.5 Regulatory framework
3.6 Gamma oryzanol market dynamics
3.6.1 Market driver analysis
3.6.1.1 Growing sports supplements industry
3.6.1.2 Growing natural ingredients demand in cosmetics
3.6.2 Market restraint analysis
3.6.2.1 Low consumer awareness
3.7 Key opportunities prioritized
3.8 Gamma oryzanol - Porter’s analysis
3.9 Gamma oryzanol - PESTEL analysis
CHAPTER 4 GAMMA ORYZANOL APPLICATION OUTLOOK
4.1 Global gamma oryzanol market share by application, 2014 & 2022
4.2 Sports Supplements
4.2.1 Market estimates and forecast, 2012 - 2022
4.2.2 Market estimates and forecast by region, 2012 - 2022
4.3 Cosmetics
4.3.1 Market estimates and forecast, 2012 - 2022
4.3.2 Market estimates and forecast by region, 2012 - 2022
4.4 Pharmaceuticals
4.4.1 Market estimates and forecast, 2012 - 2022
4.4.2 Market estimates and forecast by region, 2012 - 2022
4.5 Animal feed
4.5.1 Market estimates and forecast, 2012 - 2022
4.5.2 Market estimates and forecast by region, 2012 - 2022
CHAPTER 6 GAMMA ORYZANOL REGIONAL OUTLOOK
6.1 Global gamma oryzanol market volume share by region, 2014&2022
6.2 North America
6.2.1 Market estimates and forecast, 2012 - 2022
6.2.2 Market estimates and forecast by application, 2012 - 2022
6.2.3 U.S.
6.2.4.1 Market estimates and forecast, 2012 - 2022
6.2.4.2 Market estimates and forecast by application, 2012 - 2022
6.3 Europe
6.3.1 Market estimates and forecast, 2012 - 2022
6.3.2 Market estimates and forecast by application, 2012 - 2022
6.3.3 France
6.3.4.1 Market estimates and forecast, 2012 - 2022
6.3.4.2 Market estimates and forecast by application, 2012 - 2022
6.3.4 Germany
6.3.5.1 Market estimates and forecast, 2012 - 2022
6.3.5.2 Market estimates and forecast by application, 2012 - 2022
6.3.5 UK
6.3.6.1 Market estimates and forecast, 2012 - 2022
6.3.6.2 Market estimates and forecast by application, 2012 - 2022
6.4 Asia Pacific
6.4.1 Market estimates and forecast, 2012 - 2022
6.4.2 Market estimates and forecast by application, 2012 - 2022
6.4.3 China
6.4.4.1 Market estimates and forecast, 2012 - 2022
6.4.4.2 Market estimates and forecast by application, 2012 - 2022
6.4.4 India
6.4.5.1 Market estimates and forecast, 2012 - 2022
6.4.5.2 Market estimates and forecast by application, 2012 - 2022
6.5 Central & South America (CSA)
6.5.1 Market estimates and forecast, 2012 - 2022
6.5.2 Market estimates and forecast by application, 2012 - 2022
6.6 Middle East & Africa (MEA)
6.6.1 Market estimates and forecast, 2012 - 2022
6.6.2 Market estimates and forecast by application, 2012 - 2022
CHAPTER 7 COMPETITIVE LANDSCAPE
7.1 Oryza Oil & Fat Chemical Co., Ltd
7.1.1 Company Overview
7.1.2 Financial Performance
7.1.3 Product Benchmarking
7.1.4 Strategic Initiatives
7.2 Jining Ankang Pharmaceutical
7.2.1 Company Overview
7.2.2 Financial Performance
7.2.3 Product Benchmarking
7.2.4 Strategic Initiatives
7.3 KangCare
7.3.1 Company Overview
7.3.2 Financial Performance
7.3.3 Product Benchmarking
7.3.4 Strategic Initiatives
7.4 Lamotte Oils
7.4.1 Company Overview
7.4.2 Financial Performance
7.4.3 Product Benchmarking
7.4.4 Strategic Initiatives
7.5 Tsuno Rice
7.5.1 Company Overview
7.5.2 Financial Performance
7.5.3 Product Benchmarking
7.5.4 Strategic Initiatives
7.6 Xi'an Realin Biotechnology
7.6.1 Company Overview
7.6.2 Financial Performance
7.6.3 Product Benchmarking
7.6.4 Strategic Initiatives
7.7 Honson Pharmatech Group
7.7.1 Company Overview
7.7.2 Financial Performance
7.7.3 Product Benchmarking
7.7.4 Strategic Initiatives
7.8 Shanghai Freemen, LLC
7.8.1 Company Overview
7.8.2 Financial Performance
7.8.3 Product Benchmarking
7.8.4 Strategic Initiatives
7.9 Chromadex International
7.9.1 Company Overview
7.9.2 Financial Performance
7.9.3 Product Benchmarking
7.9.4 Strategic Initiatives
7.10 Sunrise Nutrachem Group Co., Ltd.
7.10.1 Company Overview
7.10.2 Financial Performance
7.10.3 Product Benchmarking
7.10.4 Strategic Initiatives
